Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.2M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
2.23M
-
Shares change
-
-53.3K
-
Total reported value, excl. options
-
$125M
-
Value change
-
-$3.53M
-
Number of buys
-
47
-
Number of sells
-
-51
-
Price
-
$56.04
Significant Holders of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) as of Q1 2025
123 filings reported holding UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares as of Q1 2025.
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.23M shares
of 3.2M outstanding shares and own 69.68% of the company stock.
Largest 10 shareholders include BRANDES INVESTMENT PARTNERS, LP (242K shares), RENAISSANCE TECHNOLOGIES LLC (218K shares), DIMENSIONAL FUND ADVISORS LP (193K shares), VANGUARD GROUP INC (176K shares), BlackRock, Inc. (161K shares), GEODE CAPITAL MANAGEMENT, LLC (108K shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (102K shares), Minerva Advisors LLC (86.9K shares), STATE STREET CORP (80.2K shares), and RICE HALL JAMES & ASSOCIATES, LLC (73.8K shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.